WeightWatchers' CEO of roughly two years, Sima Sistani, is out. She helped push the company into the white-hot weight-loss ...

Shares of Weight Watchers parent company WW International (WW) rose nearly 40% after the company announced plans to begin ...

With the addition of compounded semaglutide [GLP-1], we are expanding our offering to include a clinical weight management ...

WW International, known as WeightWatchers, saw its stock soar on new of its new compounded GLP-1 offering. But analysts say ...

Shares of WW International, better known as WeightWatchers, soared Tuesday after it said it is offering copycat weight-loss ...

WeightWatchers stock rises after the company announces compounded semaglutide offerings, addressing GLP-1 shortages while ...

WeightWatchers said it will sell compounded versions of semaglutide — the key ingredient in Novo Nordisk's Ozempic and Wegovy ...

High demand has created a market for compounded versions of the drug best known as Ozemic or Wegovy, but doctors and the FDA ...

周三，Truist Securities维持对Hims & Hers Health, Inc. (NYSE:HIMS)股票的持有评级，目标价为23.00美元。该公司的立场是在近期股票波动的背景下做出的，这种波动被认为部分受到几个因素的影响。其中一个影响股票波动的因素是该公司被纳入小型股S&P 600指数，这被视为一个积极因素。 另一个因素是Weight Watchers宣布推出新的复合塞马格鲁肽产 ...

Shares of WeightWatchers (WW) are climbing after the company announced a compounded GLP-1 medication starting at $129 as it ...

The company's move to include this alternative is designed to offer a more accessible and affordable option for individuals seeking weight loss support. The addition of semaglutide, a medication ...

NEW YORK - WeightWatchers (NASDAQ: WW) introduced compounded semaglutide to its weight management program, aiming to provide members with a clinically supported treatment option in the face of ...